Sharing Of Scientific Data Posed As Way To Diminish Fraud

WASHINGTON-Sharing notebooks and other data with someone outside their laboratory is an idea that is anathema to many scientists. But they may need to get used to it as part of the price of performing science with public funds. The search for a better system to record, retain, and share data is emerging as a key issue in the ongoing debate over how to curb scientific misconduct. It promises to remain a significant issue long after scientists have finished arguing about whether Rep. John Dingell

Written byJeffrey Mervis
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The search for a better system to record, retain, and share data is emerging as a key issue in the ongoing debate over how to curb scientific misconduct. It promises to remain a significant issue long after scientists have finished arguing about whether Rep. John Dingell (D-Mich.) was justified in his grilling of Nobel laureate David Baltimore last month in connection with allegations of errors in a 1986 Cell paper that the MIT biologist coauthored.

At the same time, the two days of hearings before Dingell's oversight and investigations panel of the House Energy and Commerce Committee (see excerpts on page 11) have highlighted some of the problems with how researchers keep their data. In particular, many scientists say that they are troubled by the admission of another Cell coauthor, Tufts University immunologist Thereza Imanishi-Kari, that she occasionally recorded data from experiments months after they had been performed. Imanishi-Kari also ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies